50% cases were lately used disease modifying anti-rheumatic drugs (DMARDs) at the beginning and all cases were corticoid-dependent JIA with an average dose of 0.99 ± 0.33 mg / kg / day; 53.6% cases were used biological therapy with Tocilizumab and achieve ACR - Pedi reponse after 3 - 6 months.